DR. DANIEL ARTHUR WATROUS M.D.
NPI 1841246568
Internal Medicine - Rheumatology in Visalia, CA

Active since May 25, 2006PECOS EnrolledAccepts Medicare Assignment
75/100
CMS Quality Rating
5315 W HILLSDALE AVE, VISALIA, CA 93291(559) 732-9900(559) 732-9908 Get Directions Write a Review

NPPES record last updated: February 24, 2025. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Feb 24, 2025, Nov 14, 2023, May 19, 2022 (3 updates tracked since 2022).

About Dr. Daniel Arthur Watrous M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. DANIEL ARTHUR WATROUS M.D. (NPI 1841246568) is an individual rheumatology provider in Visalia, California, licensed in California (G55060) and active in the NPI registry since May 2006. He is enrolled in Medicare PECOS, maintains 2 additional practice locations, and is a graduate of Oral Roberts University School Of Medicine (1984).

NPPES Registry Identity

NPI1841246568
Entity TypeIndividualMale
Primary Taxonomy207RR0500X
Provider Legal NameDR. DANIEL ARTHUR WATROUSCredential: M.D.
Location Address5315 W HILLSDALE AVEVisalia, CA 93291-5118
Mailing Address5315 W. Hillsdale AvenueVisalia, CA 93291-5118 · (559) 732-9900 · Fax (559) 732-9900
Fax(559) 732-9908
Sole ProprietorYes
Medical School CMSOral Roberts University School Of MedicineGraduated 1984
Enumeration DateMay 25, 2006
Last NPPES UpdateFebruary 24, 20253 updates tracked since enumeration
NPPES CertifiedFebruary 24, 2025
NPI 1841246568 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · RheumatologyAllopathic & Osteopathic Physicians
Taxonomy Code207RR0500X
License Licensed in CA · G55060
Definition
An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.
5315 W HILLSDALE AVE, Visalia, CA 93291

Secondary Practice Locations 2

Location 1671 W Tefft St Ste 13Nipomo, CA 93444-8988 · Phone (805) 473-4001
Location 26327 N Fresno St Ste 101Fresno, CA 93710-5236 · Phone (559) 732-9900 · Fax (559) 732-9909

Other Identifiers 1

Medicaid00G550601CA

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Daniel Arthur Watrous M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID3577632694
PECOS Enrollment IDI20080515000366
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 24

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, tocilizumab, 1 mg J3262
Tocilizumab is a medication administered via injection. It's used to treat certain conditions like rheumatoid arthritis by reducing inflammation in the body. It works by blocking a substance in the body that leads to inflammation.
81,740 services25 patients
Injection, golimumab, 1 mg, for intravenous use J1602
Golimumab is a medication given through an IV (a small tube in your vein). It helps to reduce inflammation and pain by blocking a protein in your body that causes inflammation. It's often used to treat conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
76,850 services98 patients
Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
42,210 services41 patients
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717
Certolizumab pegol is a medication injected under a doctor's supervision. It's used to treat certain inflammatory conditions like rheumatoid arthritis. The injection helps reduce symptoms like pain and swelling. Note that this drug isn't for self-administration.
40,400 services18 patients
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129
Abatacept is a medication administered via injection under a doctor's supervision. It's used to treat conditions like rheumatoid arthritis by moderating the immune system. This code applies when the doctor administers the drug, not for self-administration.
27,500 services55 patients
Injection, infliximab, excludes biosimilar, 10 mg J1745
Infliximab is a medication given via injection to treat certain autoimmune conditions. It works by blocking the action of a substance in your body that causes inflammation. Each dose is based on your medical condition and response to treatment.
21,870 services87 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 93291 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$133.94 typical visit price
range $58.87 – $176.60
Typical copayment $33.48 (range $14.71 – $44.15)
Most-billed visit code 99204
Established Patient
$103.36 typical visit price
range $19.28 – $144.60
Typical copayment $25.84 (range $4.82 – $36.15)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

75/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored

Reported Quality Measures

Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
100%4,602 patients5/55-star benchmark: 100%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
100%2,122 patients5/55-star benchmark: 97%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
0%2,847 patients1/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months
100%608 patients5/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Functional Status Assessment
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months
100%600 patients5/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Glucocorticoid Management
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >= 10 mg daily (or equivalent) with improvement or no change in disease…
100%593 patients5/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease activity within 12 months
100%609 patients5/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Tuberculosis Screening
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have documentation of a tuberculosis (TB) screening performed and results interpreted within 6 months prior to receiving a first course of therapy using a…
100%347 patients5/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Referred Medical Equipment & Supplies CMS DME claims 2

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Heavy duty wheelchair K0006
DME-Wheelchairs · category DD000N
1 supplier12 claims12 services$39.22 avg. paid by Medicare
Elevating leg rests, pair (for use with capped rental wheelchair base) K0195
DME-Wheelchairs · category DD021N
1 supplier12 claims12 services$6.26 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 8

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Nurse Practitioner
5315 W HILLSDALE AVE
VISALIA, CA 93291
Nurse Practitioner
5315 W HILLSDALE AVE
VISALIA, CA 93291
Nurse Practitioner (Family)
5315 W HILLSDALE AVE
VISALIA, CA 93291
Nurse Practitioner
5315 W HILLSDALE AVE
VISALIA, CA 93291
Internal Medicine (Rheumatology)
5315 W HILLSDALE AVE
VISALIA, CA 93291
Non-Pharmacy Dispensing Site
5315 W HILLSDALE AVE
VISALIA, CA 93291
Internal Medicine (Rheumatology)
5315 W HILLSDALE AVE
VISALIA, CA 93291
Physician Assistant
5315 W HILLSDALE AVE
VISALIA, CA 93291

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Daniel Watrous's NPI number?

The NPI number for Daniel Watrous is 1841246568. It was assigned to this individual provider in the NPPES registry on May 25, 2006.

Where is Daniel Watrous located?

Daniel Watrous practices at 5315 W Hillsdale Ave, Visalia, CA 93291. The listed phone number is (559) 732-9900.

What is Daniel Watrous's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Rheumatology, with taxonomy code 207RR0500X.

Is Daniel Watrous enrolled in Medicare?

Yes. Daniel Watrous is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Daniel Watrous was last updated on February 24, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 17 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.